Thursday, July 9, 2026

pharma · Netherton Syndrome · QNRX

Quoin Pharmaceuticals

Quoin Pharmaceuticals clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Ashburn, USA HQ
2018 Founded
9 Employees
Public company Type
QNRX · NYSE Ticker
Company details
Intelligence · Clinical Programs

Quoin Pharmaceuticals projects

3 ClinicalTrials.gov programs sponsored by Quoin Pharmaceuticals.

Quoin Pharmaceuticals has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. QRX003

    Quoin Pharmaceuticals,

    Netherton Syndrome

    phase 3 small molecule active

    1 trial
  2. QRX003, 4% Lotion

    Quoin Pharmaceuticals,

    Netherton Syndrome

    phase 3 small molecule active

    2 trials
  3. QRX003-2% Lotion

    Quoin Pharmaceuticals,

    Netherton Syndrome

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Quoin Pharmaceuticals have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.